• Je něco špatně v tomto záznamu ?

Molecularly imprinted polymers in biological applications

Z. El-Schich, Y. Zhang, M. Feith, S. Beyer, L. Sternbæk, L. Ohlsson, M. Stollenwerk, AG. Wingren

. 2020 ; 69 (6) : 406-419. [pub] 20201001

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc22004766

Grantová podpora
Biofilms Research Center for Biointerfaces
721297 Horizon 2020 Framework Programme
20160165 Knowledge Foundation
Malmö University
Allmänna Sjukhusets i Malmö Stiftelse för Bekämpande av Cancer

Molecularly imprinted polymers (MIPs) are currently widely used and further developed for biological applications. The MIP synthesis procedure is a key process, and a wide variety of protocols exist. The templates that are used for imprinting vary from the smallest glycosylated glycan structures or even amino acids to whole proteins or bacteria. The low cost, quick preparation, stability and reproducibility have been highlighted as advantages of MIPs. The biological applications utilizing MIPs discussed here include enzyme-linked assays, sensors, in vivo applications, drug delivery, cancer diagnostics and more. Indeed, there are numerous examples of how MIPs can be used as recognition elements similar to natural antibodies.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22004766
003      
CZ-PrNML
005      
20220127145008.0
007      
ta
008      
220113s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.2144/btn-2020-0091 $2 doi
035    __
$a (PubMed)33000637
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a El-Schich, Zahra $u Department of Biomedical Sciences, Faculty of Health & Society, Malmö University, Malmö, Sweden
245    10
$a Molecularly imprinted polymers in biological applications / $c Z. El-Schich, Y. Zhang, M. Feith, S. Beyer, L. Sternbæk, L. Ohlsson, M. Stollenwerk, AG. Wingren
520    9_
$a Molecularly imprinted polymers (MIPs) are currently widely used and further developed for biological applications. The MIP synthesis procedure is a key process, and a wide variety of protocols exist. The templates that are used for imprinting vary from the smallest glycosylated glycan structures or even amino acids to whole proteins or bacteria. The low cost, quick preparation, stability and reproducibility have been highlighted as advantages of MIPs. The biological applications utilizing MIPs discussed here include enzyme-linked assays, sensors, in vivo applications, drug delivery, cancer diagnostics and more. Indeed, there are numerous examples of how MIPs can be used as recognition elements similar to natural antibodies.
650    _2
$a zvířata $7 D000818
650    _2
$a biologické markery $x analýza $7 D015415
650    _2
$a lékové transportní systémy $7 D016503
650    _2
$a molekulárně imprintované polymery $x chemická syntéza $x chemie $7 D000082582
650    _2
$a nádory $x patologie $7 D009369
650    _2
$a polymerizace $7 D058105
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Zhang, Yuecheng $u Department of Biomedical Sciences, Faculty of Health & Society, Malmö University, Malmö, Sweden $u Biofilms-Research Center for Biointerfaces, Malmö University, Malmö, Sweden
700    1_
$a Feith, Marek $u Department of Biomedical Sciences, Faculty of Health & Society, Malmö University, Malmö, Sweden $u Department of Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Beyer, Sarah $u Department of Biomedical Sciences, Faculty of Health & Society, Malmö University, Malmö, Sweden $u Biofilms-Research Center for Biointerfaces, Malmö University, Malmö, Sweden
700    1_
$a Sternbæk, Louise $u Department of Biomedical Sciences, Faculty of Health & Society, Malmö University, Malmö, Sweden $u Biofilms-Research Center for Biointerfaces, Malmö University, Malmö, Sweden $u Phase Holographic Imaging AB, Lund, Sweden
700    1_
$a Ohlsson, Lars $u Department of Biomedical Sciences, Faculty of Health & Society, Malmö University, Malmö, Sweden $u Biofilms-Research Center for Biointerfaces, Malmö University, Malmö, Sweden
700    1_
$a Stollenwerk, Maria $u Department of Biomedical Sciences, Faculty of Health & Society, Malmö University, Malmö, Sweden $u Biofilms-Research Center for Biointerfaces, Malmö University, Malmö, Sweden
700    1_
$a Wingren, Anette Gjörloff $u Department of Biomedical Sciences, Faculty of Health & Society, Malmö University, Malmö, Sweden $u Biofilms-Research Center for Biointerfaces, Malmö University, Malmö, Sweden
773    0_
$w MED00000790 $t BioTechniques $x 1940-9818 $g Roč. 69, č. 6 (2020), s. 406-419
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33000637 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127145005 $b ABA008
999    __
$a ok $b bmc $g 1752064 $s 1155915
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 69 $c 6 $d 406-419 $e 20201001 $i 1940-9818 $m BioTechniques $n Biotechniques $x MED00000790
GRA    __
$p Biofilms Research Center for Biointerfaces
GRA    __
$a 721297 $p Horizon 2020 Framework Programme
GRA    __
$a 20160165 $p Knowledge Foundation
GRA    __
$p Malmö University
GRA    __
$p Allmänna Sjukhusets i Malmö Stiftelse för Bekämpande av Cancer
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Možnosti archivace